FDAnews
www.fdanews.com/articles/150502-ben-venue-rsquo-s-bedford-plant-resumes-producing-some-generic-injectables

Ben Venue’s Bedford Plant Resumes Producing Some Generic Injectables

October 26, 2012
Ben Venue’s Bedford, Ohio, plant — in the news this past year for quality problems — has restarted a handful of production lines to make some of its critical-need drugs available again. Injectable generics such as radiotherapy drug amifostine, muscle relaxant vecuronium, chemotherapy drug gemcitabine and vasodilator phentolamine are once more returning to market shelves.
Generic Line